The results indicate that gliclazide has an anti-oxidant and anti-inflammatory effect, including leukocyte migration and influence on MDA, MPO, NFκB, IL-1β, TNF-α, COX2, MMP-2, iNOS, and P-selectin levels, improving OM (Figure 7). The gene discussed is IL1B; the disease is ocular melanoma.